about
Medical Therapy of Perianal Crohn's DiseasePharmacologic therapy for inflammatory bowel disease refractory to steroidsOptimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug WithdrawalImmune Thrombocytopenic Purpura During Maintenance Phase of Acute Lymphoblastic Leukemia: A Rare Coexistence Requiring a High Degree of Suspicion, a Case Report and Review of the Literature.Use of thiopurines in inflammatory bowel disease: Safety issues.Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside.Thiopurine-induced pancreatitis in inflammatory bowel diseases.Probing the Association of Pancreatitis in Inflammatory Bowel Disease.Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?Novel Tetra-Primer ARMS-PCR Assays for Thiopurine Intolerance Susceptibility Mutations NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C) in East Asians.Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis.Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.Critical assessment of thioguanine treatment for inflammatory bowel diseases: Is it time to rehabilitate this treatment?Capillary Electrophoresis Hyphenated with Mass Spectrometry for Determination of Inflammatory Bowel Disease Drugs in Clinical Urine Samples.Comparison of TPMT and NUDT15 polymorphisms in Chinese patients with inflammatory bowel disease.Medical and surgical management of perianal Crohn's disease.
P2860
Q26777722-D39A8570-C32E-4459-BEAA-EC0BF776D960Q26796415-46E700E2-DB50-44EE-A8CD-ED0940336B7FQ26801119-FED562D2-E261-48EA-B1E4-38C7C9DC2A53Q33422337-940579CA-8CC5-4494-B917-56BEFB7CB1BCQ33621267-6BE21625-0A61-448A-BF03-2680ABCB611FQ35066350-84AA1222-642D-414C-9A83-C4699AAACDCAQ37114622-2D00E245-88A6-42B0-AE9D-93F715F4AE5CQ37660708-1C9D8FAF-52B2-4BF5-BA5C-CDF621DDB706Q38248113-3F5D3AEA-47D7-464B-B484-25BE0CA08925Q38286123-58930352-9390-45C9-83E6-5DC302C850FDQ38624953-8085D097-7CB9-4FCC-958F-27B6D3AE68E0Q38973323-CB60057A-9021-42E0-8604-754436E21DF7Q40478934-4C27ED7E-BE59-4A98-9252-BB66F26AA113Q47114058-59561E63-FB9E-4522-ACA8-9F86C0E27240Q47130594-EA00B8E0-9BEC-44BE-86B2-B864FE52693FQ47641815-D8FF8564-C294-4749-8C78-E308D941B0D5Q48188262-6FC8CB01-AA1F-4972-87D5-B557D94867BDQ50001403-FECE3937-89AE-4D11-BB9B-111AC9E9FD40Q50331718-592235FE-3895-4450-8317-FA6BDE7B0692Q55103450-A5DEED38-5C70-4971-87E2-08A76B03B9D9
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Thiopurines in inflammatory bowel disease revisited
@ast
Thiopurines in inflammatory bowel disease revisited
@en
type
label
Thiopurines in inflammatory bowel disease revisited
@ast
Thiopurines in inflammatory bowel disease revisited
@en
prefLabel
Thiopurines in inflammatory bowel disease revisited
@ast
Thiopurines in inflammatory bowel disease revisited
@en
P2093
P2860
P356
P1476
Thiopurines in inflammatory bowel disease revisited
@en
P2093
Christian Sina
Florian Bär
Klaus Fellermann
P2860
P304
P356
10.3748/WJG.V19.I11.1699
P407
P577
2013-03-01T00:00:00Z